Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin | Matthew Coldiron
1 Görünümler
• 06/15/23
0
0
gömmek
administrator
Aboneler
A study conducted in Mozambique shows pegylated liposomal doxorubicin (PLD) was safe, well-tolerated and effective as first-line treatment for Kaposi’s sarcoma, a common HIV-associated malignancy.
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar